| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other non-current assets | 530 | 546 | 556 | 556 |
| Total assets | 12,135 | 12,010 | 12,704 | 15,803 |
| Other current liabilities | 73 | 192 | 252 | 69 |
| Total current liabilities | 1,681 | 1,572 | 1,604 | 2,201 |
| Deferred revenue, non-current | 157 | 65 | 58 | 95 |
| Operating lease liabilities, non-current | 660 | 666 | 667 | 679 |
| Financing lease liabilities, non-current | 26 | 32 | 35 | 625 |
| Other non-current liabilities | 281 | 276 | 274 | 276 |
| Total liabilities | 2,805 | 2,611 | 2,638 | 3,876 |
| Additional paid-in capital | 1,254 | 1,127 | 982 | 751 |
| Accumulated other comprehensive income (loss) | 27 | 23 | 10 | 11 |
| Retained earnings | 8,049 | 8,249 | 9,074 | 11,165 |
| Total stockholders equity | 9,330 | 9,399 | 10,066 | 11,927 |
| Total liabilities and stockholders equity | 12,135 | 12,010 | 12,704 | 15,803 |
Moderna, Inc. (MRNA)
Moderna, Inc. (MRNA)